JP2008537958A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008537958A5 JP2008537958A5 JP2008506722A JP2008506722A JP2008537958A5 JP 2008537958 A5 JP2008537958 A5 JP 2008537958A5 JP 2008506722 A JP2008506722 A JP 2008506722A JP 2008506722 A JP2008506722 A JP 2008506722A JP 2008537958 A5 JP2008537958 A5 JP 2008537958A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- wisp
- domain
- cancer cells
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/105,876 | 2005-04-14 | ||
| US11/105,876 US7455834B2 (en) | 2002-06-29 | 2005-04-14 | Methods and compositions for modulating and detecting WISP activity |
| PCT/US2006/014008 WO2006113402A1 (en) | 2005-04-14 | 2006-04-13 | Methods and compositions for modulating and detecting wisp activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008537958A JP2008537958A (ja) | 2008-10-02 |
| JP2008537958A5 true JP2008537958A5 (https=) | 2009-05-28 |
| JP4979684B2 JP4979684B2 (ja) | 2012-07-18 |
Family
ID=36809580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008506722A Expired - Lifetime JP4979684B2 (ja) | 2005-04-14 | 2006-04-13 | Ｗｉｓｐ活性を調節し検出するための方法及び組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7455834B2 (https=) |
| EP (1) | EP1869086B1 (https=) |
| JP (1) | JP4979684B2 (https=) |
| KR (1) | KR101320261B1 (https=) |
| CN (1) | CN101198623B (https=) |
| AU (1) | AU2006236649B2 (https=) |
| BR (1) | BRPI0612184A8 (https=) |
| CA (1) | CA2604933C (https=) |
| ES (1) | ES2388993T3 (https=) |
| IL (1) | IL186095A (https=) |
| MX (1) | MX2007012798A (https=) |
| NO (1) | NO20075825L (https=) |
| NZ (1) | NZ561709A (https=) |
| RU (1) | RU2412201C2 (https=) |
| WO (1) | WO2006113402A1 (https=) |
| ZA (1) | ZA200708738B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7455834B2 (en) * | 2002-06-29 | 2008-11-25 | Genentech, Inc. | Methods and compositions for modulating and detecting WISP activity |
| KR102148303B1 (ko) | 2012-02-11 | 2020-08-26 | 제넨테크, 인크. | R-스폰딘 전위 및 그의 사용 방법 |
| MX2015013658A (es) * | 2013-03-27 | 2016-02-18 | Ge Healthcare As | Metodo y reactivo para preparar una composicion diagnostica. |
| KR20160138580A (ko) | 2014-04-15 | 2016-12-05 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Wisp1에 결합하는 항원 결합 단백질 |
| KR102011366B1 (ko) * | 2016-11-17 | 2019-10-14 | 연세대학교 산학협력단 | 암 전이 억제제의 스크리닝 방법 |
| EP3795170B1 (en) * | 2018-05-17 | 2024-03-20 | Olives Biotherapeutics Inc. | Pharmaceutical composition comprising ccn5 as active ingredient for preventing or treating retinal diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| EP2014770A3 (en) | 1997-10-29 | 2009-02-18 | Genentech, Inc. | WNT-1 Iinduced secreted polypeptide WISP-2 |
| ATE363489T1 (de) | 1999-03-08 | 2007-06-15 | Genentech Inc | In tumoren vervielfältigte gensequenzen und deren diagnostische verwendungen |
| US7455834B2 (en) * | 2002-06-29 | 2008-11-25 | Genentech, Inc. | Methods and compositions for modulating and detecting WISP activity |
| ATE476447T1 (de) | 2002-06-29 | 2010-08-15 | Genentech Inc | Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität |
| WO2005025603A2 (en) | 2003-09-11 | 2005-03-24 | Genentech, Inc. | Methods of using wisp antagonists |
-
2005
- 2005-04-14 US US11/105,876 patent/US7455834B2/en not_active Expired - Lifetime
-
2006
- 2006-04-13 RU RU2007142005/10A patent/RU2412201C2/ru not_active IP Right Cessation
- 2006-04-13 ES ES06750127T patent/ES2388993T3/es not_active Expired - Lifetime
- 2006-04-13 CN CN2006800215473A patent/CN101198623B/zh not_active Expired - Lifetime
- 2006-04-13 NZ NZ561709A patent/NZ561709A/en not_active IP Right Cessation
- 2006-04-13 EP EP06750127A patent/EP1869086B1/en not_active Expired - Lifetime
- 2006-04-13 BR BRPI0612184A patent/BRPI0612184A8/pt active Search and Examination
- 2006-04-13 CA CA2604933A patent/CA2604933C/en not_active Expired - Fee Related
- 2006-04-13 JP JP2008506722A patent/JP4979684B2/ja not_active Expired - Lifetime
- 2006-04-13 MX MX2007012798A patent/MX2007012798A/es active IP Right Grant
- 2006-04-13 AU AU2006236649A patent/AU2006236649B2/en not_active Ceased
- 2006-04-13 WO PCT/US2006/014008 patent/WO2006113402A1/en not_active Ceased
- 2006-04-13 ZA ZA200708738A patent/ZA200708738B/xx unknown
- 2006-04-13 KR KR1020077023542A patent/KR101320261B1/ko not_active Expired - Fee Related
-
2007
- 2007-09-20 IL IL186095A patent/IL186095A/en not_active IP Right Cessation
- 2007-11-13 NO NO20075825A patent/NO20075825L/no not_active Application Discontinuation
-
2008
- 2008-10-20 US US12/254,649 patent/US7732567B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20150432T1 (hr) | Indentifikacija antigena povezanih s tumorom za dijagnozu i terapiju | |
| RU2012137503A (ru) | Лекарственный препарат для лечения и/или профилактики рака | |
| HRP20240495T1 (hr) | Anti-garp antitijelo | |
| CY1117031T1 (el) | Μονοκλωνικα αντισωματα εναντι claudin-18 στην αγωγη εναντι καρκινου | |
| SI2342234T1 (en) | MONOCOLIC ANTI-GT468 CANCER CANCER PROTITEL | |
| RU2013155455A (ru) | Антитела для лечения раковых заболеваний, при которых эскспрессируется клаудин 6 | |
| RU2014141151A (ru) | Диагностика и лечение злокачественной опухоли с использованием антитела против ereg | |
| RU2016146389A (ru) | Улучшенные полиэтилениминовые полиэтиленгликолевые векторы | |
| RU2017138468A (ru) | Антитела против человеческого her3, имеющие низкое содержание фукозы, и области их применения | |
| NZ704295A (en) | Compositions and methods for the treatment of infections and tumors | |
| RU2012140185A (ru) | Ингибирование ангиогенеза | |
| HK1255815A1 (zh) | 治疗腹膜癌的组合物和方法 | |
| RU2014134923A (ru) | Антагонисты alk1 и их применение в лечении почечно-клеточного рака | |
| MX2019009121A (es) | Antcuerpos anti-kaag1 o fragmento de union al antigeno del mismo para el tratamiento de cancer de mama triple negativo. | |
| GEAP202416383A (en) | Use of medicament in treatment of tumor disease | |
| MX2022005704A (es) | Peptidos antigenicos para la prevencion y el tratamiento de malignidad de celulas b. | |
| HRP20231636T1 (hr) | Igg epitop i njegova primjena kao cilja | |
| JP2008537958A5 (https=) | ||
| GB2474807A (en) | Vhz for diagnosis and treatment of cancers | |
| BRPI0707247B8 (pt) | vacina para tumor compreendendo células tumorais alogênicas ou xenogênicas | |
| Hana et al. | Molecular Targeting of the Claudins Pathway. | |
| ES2348161T3 (es) | Métodos para dañar células usando funciones efectoras de anticuerpos anti-gfra1. | |
| EA202193346A1 (ru) | Способы лечения злокачественных опухолей мочевыделительной системы | |
| EA202091688A1 (ru) | Конъюгаты антител к тканевому фактору с лекарственными средствами и их применение при лечении рака | |
| MX2025005210A (es) | Anticuerpos anti-avb6 y conjugados anticuerpo-fármaco y su uso en el tratamiento del cáncer |